Science 37 to go public with LifeSci Acquisition II merger
Science 37, a digital clinical trial operating system developer, has agreed to go public via a definitive agreement to merge…
IPO Industry
Latest in
IPO Industry
Altasciences completes acquisition of US-based CRO WCCT Global
Mid-size CRO/CDMO Altasciences has acquired early-stage clinical research organisation (CRO) WCCT Global.
Ripple Therapeutics to consider $75m-plus IPO in 2023, or Series B, post Phase II trial data, says CEO
Ripple Therapeutics is eyeing a $75m-plus initial public offering (IPO) in 2023, said CEO Tom Reeves. A company evaluation of…
By
QSAM Biosciences closes financing to fund upcoming clinical trials
US-based biotechnology company QSAM Biosciences has announced the closing of its $2.5m Series B financing round to fund its upcoming…
Covid-19 Phase III trial of Eiger’s interferon to start pending ongoing $10m financing, primary investigator says
A Phase III investigator-led trial studying Eiger BioPharmaceuticals’ hepatitis D virus (HDV) asset peginterferon lambda (IFN-lambda) in Covid-19 is building…
By
Kayentis raises funding to accelerate digital platform expansion for trials
Digital data capture technologies provider Kayentis has raised about $8.3m in growth capital in an effort to accelerate the expansion…
New Series B financing enables Reify Health to integrate trials
Cloud-based solutions provider Reify Health has raised $30m through Series B financing to advance its tools for the clinical trial…
IMV receives funding for trials of its Covid-19 vaccine candidate
Clinical-stage biopharmaceutical company IMV has announced that the government agencies of Canada will invest up to C$4.75m ($3.58m) in IMV’s…